Naproxène in Canada
99 medicine records from 23 holders carry this name in the official sources. Collected on November 11, 2026.
Medicines, page 2
| Name | Holder | Status | Code |
|---|---|---|---|
| NAPROXEN LIQUID GELS · 200 MG · CAPSULE | JUNO OTC INC | cancelled |
DIN
02539969DPD drug code
102869
|
| NOVO-NAPROX TAB 125MG · 125 MG · TABLET | NOVOPHARM LIMITED | cancelled |
DIN
00565369DPD drug code
5037
|
| NTP-NAPROXEN · 250 MG · TABLET | TEVA CANADA LIMITED | cancelled |
DIN
02346583DPD drug code
83201
|
| NTP-NAPROXEN · 375 MG · TABLET | TEVA CANADA LIMITED | cancelled |
DIN
02346591DPD drug code
83202
|
| NTP-NAPROXEN · 500 MG · TABLET | TEVA CANADA LIMITED | cancelled |
DIN
02346605DPD drug code
83203
|
| NTP-NAPROXEN EC · 250 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | cancelled |
DIN
02346613DPD drug code
83204
|
| NTP-NAPROXEN EC · 375 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | cancelled |
DIN
02346621DPD drug code
83205
|
| NTP-NAPROXEN EC · 500 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | cancelled |
DIN
02346648DPD drug code
83206
|
| NU-NAPROX EC · 250 MG · TABLET (ENTERIC-COATED) | NU-PHARM INC | cancelled |
DIN
02336553DPD drug code
82212
|
| NU-NAPROX EC · 375 MG · TABLET (ENTERIC-COATED) | NU-PHARM INC | cancelled |
DIN
02336561DPD drug code
82213
|
| NU-NAPROX EC · 500 MG · TABLET (ENTERIC-COATED) | NU-PHARM INC | cancelled |
DIN
02336588DPD drug code
82214
|
| NU-NAPROX TAB 125MG · 125 MG · TABLET | NU-PHARM INC | cancelled |
DIN
00865621DPD drug code
11187
|
| NU-NAPROX TAB 250MG · 250 MG · TABLET | NU-PHARM INC | cancelled |
DIN
00865648DPD drug code
11184
|
| NU-NAPROX TAB 375MG · 375 MG · TABLET | NU-PHARM INC | cancelled |
DIN
00865656DPD drug code
11185
|
| NU-NAPROX TAB 500MG · 500 MG · TABLET | NU-PHARM INC | cancelled |
DIN
00865664DPD drug code
11186
|
| PEDIAPHARM NAPROXEN SUSPENSION · 25 MG per ML · SUSPENSION | MEDEXUS PHARMACEUTICALS INC. | authorised |
DIN
02162431DPD drug code
19661
|
| PMS-NAPROXEN EC · 375 MG · TABLET (ENTERIC-COATED) | PHARMASCIENCE INC | cancelled |
DIN
02294702DPD drug code
78005
|
| PMS-NAPROXEN EC · 500 MG · TABLET (ENTERIC-COATED) | PHARMASCIENCE INC | cancelled |
DIN
02294710DPD drug code
78006
|
| PMS-NAPROXEN · SUPPOSITORIES · 500 MG · SUPPOSITORY | PHARMASCIENCE INC | cancelled |
DIN
02017237DPD drug code
14566
|
| PRO-NAPROXEN · 250 MG · TABLET | PRO DOC LIMITEE | authorised |
DIN
02572176DPD drug code
107415
|
| PRO-NAPROXEN · 375 MG · TABLET | PRO DOC LIMITEE | authorised |
DIN
02572184DPD drug code
107416
|
| PRO-NAPROXEN · 500 MG · TABLET | PRO DOC LIMITEE | authorised |
DIN
02572192DPD drug code
107417
|
| PRO-NAPROXEN EC · 250 MG · TABLET (DELAYED-RELEASE) | PRO DOC LIMITEE | authorised |
DIN
02572141DPD drug code
107413
|
| PRO-NAPROXEN EC - 375 · 375 MG · TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | cancelled |
DIN
02310945DPD drug code
79656
|
| PRO-NAPROXEN EC · 375 MG · TABLET (DELAYED-RELEASE) | PRO DOC LIMITEE | authorised |
DIN
02572168DPD drug code
107414
|
| PRO-NAPROXEN EC · 500 MG · TABLET (DELAYED-RELEASE) | PRO DOC LIMITEE | authorised |
DIN
02310953DPD drug code
79657
|
| RATIO-NAPROXEN · 250 MG · TABLET | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
00615315DPD drug code
5797
|
| RATIO-NAPROXEN · 375 MG · TABLET | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
00615323DPD drug code
5798
|
| RATIO-NAPROXEN · 500 MG · SUPPOSITORY | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
00756814DPD drug code
13829
|
| RATIO-NAPROXEN · 500 MG · TABLET | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
00615331DPD drug code
5799
|
| RATIO-NAPROXEN E · 250 MG · TABLET (ENTERIC-COATED) | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
02231004DPD drug code
50285
|
| RATIO-NAPROXEN E · 375 MG · TABLET (ENTERIC-COATED) | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
02231005DPD drug code
50286
|
| RATIO-NAPROXEN E · 500 MG · TABLET (ENTERIC-COATED) | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | cancelled |
DIN
02231006DPD drug code
50287
|
| RHODIAPROX - 500MG/SUP · 500 MG · SUPPOSITORY | RHODIAPHARM INC | cancelled |
DIN
02229690DPD drug code
47774
|
| RIVA-NAPROXEN · 250 MG · TABLET | LABORATOIRE RIVA INC. | cancelled |
DIN
02240786DPD drug code
64377
|
| RIVA-NAPROXEN · 375 MG · TABLET | LABORATOIRE RIVA INC. | cancelled |
DIN
02240787DPD drug code
64378
|
| RIVA-NAPROXEN · 500 MG · TABLET | LABORATOIRE RIVA INC. | cancelled |
DIN
02240788DPD drug code
64379
|
| SAB-NAPROXEN · 500 MG · SUPPOSITORY | SABEX INC | cancelled |
DIN
02230477DPD drug code
49450
|
| TEVA-NAPROXEN · 250 MG · TABLET | TEVA CANADA LIMITED | authorised |
DIN
00565350DPD drug code
5036
|
| TEVA-NAPROXEN · 375 MG · TABLET | TEVA CANADA LIMITED | authorised |
DIN
00627097DPD drug code
5860
|
| TEVA-NAPROXEN · 500 MG · TABLET | TEVA CANADA LIMITED | authorised |
DIN
00589861DPD drug code
5183
|
| TEVA-NAPROXEN EC · 250 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | authorised |
DIN
02243312DPD drug code
67215
|
| TEVA-NAPROXEN EC · 375 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | authorised |
DIN
02243313DPD drug code
67216
|
| TEVA-NAPROXEN EC · 500 MG · TABLET (ENTERIC-COATED) | TEVA CANADA LIMITED | authorised |
DIN
02243314DPD drug code
67217
|
| TEVA-NAPROXEN SR · 750 MG · TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | cancelled |
DIN
02231327DPD drug code
50634
|
| VIMOVO · MODIFIED-RELEASE TABLET · 20 MG + 500 MG · TABLET (IMMEDIATE- AND DELAYED-RELEASE) | XEDITON PHARMACEUTICALS INC | authorised |
DIN
02361728DPD drug code
84677
|
| VIMOVO · MODIFIED-RELEASE TABLET · 375 MG + 20 MG · TABLET (IMMEDIATE- AND DELAYED-RELEASE) | XEDITON PHARMACEUTICALS INC | authorised |
DIN
02361701DPD drug code
84676
|
| WAYMADE-NAPROXEN · 375 MG · TABLET (ENTERIC-COATED) | WAYMADE PLC | authorised |
DIN
02463679DPD drug code
95177
|
| WAYMADE-NAPROXEN · 500 MG · TABLET (ENTERIC-COATED) | WAYMADE PLC | authorised |
DIN
02463687DPD drug code
95178
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.